What is the effect of area size when using local area practice style as an instrument?

Journal of Clinical Epidemiology

Volumn 66, Issue 8 SUPPL.8, 2013, Pages

  Brooks, John M ^a   Tang, Yuexin ^a   Chapman, Cole G ^a   Cook, Elizabeth A ^a   Chrischilles, Elizabeth A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Acute myocardial infarction; Angiotensin converting enzyme inhibitors and angiotensin receptor blockers; Instrumental variables; Local area practice styles; Local average treatment effects; Survival

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE; THIAZIDE DIURETIC AGENT; WARFARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANALYTICAL ERROR; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; FEMALE; HEALTH CARE SYSTEM; HUMAN; INSTRUMENTAL VARIABLE ANALYSIS; LOCAL AREA PRACTICE STYLE; MAJOR CLINICAL STUDY; MALE; MEDICARE; PATIENT DECISION MAKING; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SURVIVAL; TREATMENT OUTCOME;

ACUTE MYOCARDIAL INFARCTION; ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS; INSTRUMENTAL VARIABLES; LOCAL AREA PRACTICE STYLES; LOCAL AVERAGE TREATMENT EFFECTS; SURVIVAL;

AGED; AGED, 80 AND OVER; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; AUTOMOBILE DRIVING; BIAS (EPIDEMIOLOGY); CONFOUNDING FACTORS (EPIDEMIOLOGY); DATA INTERPRETATION, STATISTICAL; FAMILY PRACTICE; FEMALE; HUMANS; LEAST-SQUARES ANALYSIS; MALE; MEDICARE; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; RESIDENCE CHARACTERISTICS; TIME FACTORS; UNITED STATES;

EID: 84880241067     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2013.04.008     Document Type: Article

References (80)

1. H.C. Sox, and S.N. Goodman The methods of comparative effectiveness research Annu Rev Public Health 33 2012 425 445
2. J.M. Brooks Supplement 1. Improving characterization of study populations: the identification problem P. Velentgas, N.A. Dreyer, Developing a Protocol for Observational Comparative Effectiveness Research (OCER): A User's Guide (Prepared By Outcome DEcIDE Center [Quintiles Outcome] under Contract No. HHSA29020050016I TO10) Vol. 12-EHC099 2012 Agency for Healthcare Research and Quality Rockville, MD
3. S. Greenland An introduction to instrumental variables for epidemiologists Int J Epidemiol 29 2000 1102
4. J.P. Newhouse, and M. McClellan Econometrics in outcomes research: the use of instrumental variables Annu Rev Public Health 19 1998 17 34 (Pubitemid 28279922)
5. A.D. McMahon Approaches to combat with confounding by indication in observational studies of intended drug effects Pharmacoepidemiol Drug Saf 12 2003 551 558 (Pubitemid 37220641)
6. N. Zohoori, and D.A. Savitz Econometric approaches to epidemiologic data: relating endogeneity and unobserved heterogeneity to confounding Ann Epidemiol 7 1997 251 257 (Pubitemid 27248647)
7. J.D. Angrist, and G.W. Imbens Two-stage least squares estimation of average causal effects in models with variable treatment intensity J Am Stat Assoc 90 1995 431 442
8. J.D. Angrist, G.W. Imbens, and D. Rubin Identification of causal effects using instrumental variables J Am Stat Assoc 91 1996 444 472
9. J.D. Angrist, and A.B. Krueger Instrumental variables and the search for identification: from supply and demand to natural experiments J Econ Perspect 15 2001 69 85 (Pubitemid 33594775)
10. M. McClellan, B.J. McNeil, and J.P. Newhouse Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables JAMA 272 1994 859 866 (Pubitemid 24282095)
11. J.M. Brooks, M. McClellan, and H.S. Wong The marginal benefits of invasive treatments for acute myocardial infarction: does insurance coverage matter? Inquiry 37 1 2000 75 90 (Pubitemid 30415716)
12. K.M. Harris, and D.K. Remler Who is the marginal patient? Understanding instrumental variables estimates of treatment effects Health Serv Res 33 5 pt 1 1998 1337 1360 (Pubitemid 29006391)
13. G.W. Imbens, and J.D. Angrist Identification and estimation of local average treatment effects Econometrica 62 1994 467 475
14. G. Fang, J.M. Brooks, and E.A. Chrischilles Apples and oranges? Interpretations of risk adjustment and instrumental variable estimates of intended treatment effects using observational data Am J Epidemiol 175 2012 60 65
15. K. Wong, M.A. Campitelli, T.A. Stukel, and J.C. Kwong Estimating influenza vaccine effectiveness in community-dwelling elderly patients using the instrumental variable analysis method Arch Intern Med 172 2012 484 491
16. S.B. Zeliadt, A.L. Potosky, D.F. Penson, and R. Etzioni Survival benefit associated with adjuvant androgen deprivation therapy combined with radiotherapy for high- and low-risk patients with nonmetastatic prostate cancer Int J Radiat Oncol Biol Phys 66 2 2006 395 402 (Pubitemid 44404101)
17. G.L. Lu-Yao, P.C. Albertson, D.F. Moore, W. Shih, Y. Lin, and R.S. DiPaola Survival following primary androgen deprivation therapy among men with localized prostate cancer JAMA 300 2008 173 181 (Pubitemid 351969301)
18. J. Hadley, D. Polsky, J.S. Mandelblatt, J.M. Mitchell, J.C. Weeks, and Q. Wang An exploratory instrumental variable analysis of the outcomes of localized breast cancer treatments in a Medicare population Health Econ 12 3 2003 171 186 (Pubitemid 36322102)
19. A. Basu, J.J. Heckman, S. Navarro-Lozano, and S. Urzua Use of instrumental variables in the presence of heterogeneity and self-selection: an application to treatments of breast cancer patients Health Econ 16 11 2007 1133 1157 (Pubitemid 350065184)
20. T.A. Stukel, E.S. Fisher, D.E. Wennberg, D.A. Alter, D.J. Gottlieb, and M.J. Vermeulen Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods JAMA 297 2007 278 285 (Pubitemid 46143305)
21. J.M. Brooks, and E.A. Chrischilles Heterogeneity and the interpretation of treatment effect estimates from risk adjustment and instrumental variable methods Med Care 45 10 suppl 2 2007 S123 S130
22. J.M. Brooks, E.A. Chrischilles, S.D. Scott, and S.S. Chen-Hardee Was breast conserving surgery underutilized for early stage breast cancer? Instrumental variables evidence for stage II patients from Iowa Health Serv Res 38 2003 1385 1402 (Pubitemid 38063930)
23. G. Fang, J.M. Brooks, and E.A. Chrischilles A new method to measure geographic variation in prescription use and its implications for comparative effectiveness research Med Care 40 2010 710 717
24. C.C. Earle, J.S. Tsai, R. Gelber, M.C. Weinstein, P.J. Neumann, and J.C. Weeks Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis J Clin Oncol 19 2001 1064 1070 (Pubitemid 32176282)
25. G. Fang, J.M. Brooks, and E.A. Chrischilles Comparison of instrumental variable analysis using a new instrument with risk adjustment methods to reduce confounding by indication Am J Epidemiol 175 2012 1142 1151
26. S.W. Gray, M.B. Landrum, E.B. Lamont, B.J. McNeil, M.T. Jaklitsch, and N.L. Keating Improved outcomes associated with higher surgery rates for older patients with early stage nonsmall cell lung cancer Cancer 118 2012 1404 1411
27. J. Hadley, K.R. Yabroff, M.J. Barrett, D.F. Penson, C.S. Saigal, and A.L. Potosky Comparative effectiveness of prostate cancer treatments: evaluating statistical adjustments for confounding in observational data J Natl Cancer Inst 102 2010 1780 1793
28. J.M. Brooks, E.A. Chrischilles, M.B. Landrum, K.B. Wright, G. Fang, and E.P. Winer Survival implications associated with variation in mastectomy rates for early-staged breast cancer Int J Surg Oncol 2012 2012 127854
29. T.A. Blakely, and A.J. Woodward Ecological effects in multi-level studies J Epidemiol Community Health 54 2000 367 374 (Pubitemid 30204272)
30. J.J. Heckman Econometric causality Int Stat Rev 76 1 2008 1 27
31. J.M. Brooks, and G. Fang Interpreting treatment effect estimates with heterogeneity and choice: simulation model results Clin Ther 31 2009 902 919
32. J.D. Angrist Treatment effect heterogeneity in theory and practice Econ J 114 2004 C52 C83
33. G.S. Reeder Angiotensin converting enzyme inhibitors and receptor blockers in acute myocardial infarction: recommendations for use D.S. Basow, UpToDate 2012 UptoDate Waltham, MA
34. G.S. Reeder Angiotensin converting enzyme inhibitors and receptor blockers in acute myocardial infarction: clinical trials D.S. Basow, UpToDate 2012 UpToDate Waltham, MA
35. S. Setoguchi, R.J. Glynn, J. Avorn, M.A. Mittleman, R. Levin, and W.C. Winkelmayer Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge J Am Coll Cardiol 51 2008 1247 1254 (Pubitemid 351400891)
36. S.F. Jencks, E.D. Huff, and T. Cuerdon Change in the quality of care delivered to Medicare beneficiaries, 1998-1999 to 2000-2001 JAMA 289 2003 305 312 (Pubitemid 36083983)
37. J.J. Heckman, S. Urzua, and E. Vytlacil Understanding instrumental variables in models with essential heterogeneity Rev Econ Stat 88 3 2006 389 432 (Pubitemid 44554714)
38. C. Blais, D. Hamel, and S. Rinfret Impact of socioeconomic deprivation and area of residence on access to coronary revascularization and mortality after a first acute myocardial infarction in Quebec Can J Cardiol 28 2 2012 169 177
39. V.A. Freedman, I.B. Grafova, and J. Rogowski Neighborhoods and chronic disease onset in later life Am J Public Health 101 2011 79 86
40. S.V. Rao, K.A. Schulman, L.H. Curtis, B.J. Gersh, and J.G. Jollis Socioeconomic status and outcome following acute myocardial infarction in elderly patients Arch Intern Med 164 2004 1128 1133 (Pubitemid 38668993)
41. N. Molshatzki, Y. Drory, V. Myers, U. Goldbourt, Y. Benyamini, and D.M. Steinberg Role of socioeconomic status measures in long-term mortality risk prediction after myocardial infarction Med Care 49 2011 673 678
42. Y. Gerber, Y. Benyamini, U. Goldbourt, Y. Drory Israel Study Group on First Acute Myocardial Infarction Neighborhood socioeconomic context and long-term survival after myocardial infarction Circulation 121 2010 375 383
43. C. Tonne, J. Schwartz, M. Mittleman, S. Melly, H. Suh, and R. Goldberg Long-term survival after acute myocardial infarction is lower in more deprived neighborhoods Circulation 111 2005 3063 3070 (Pubitemid 40847783)
44. M.K. Stjarne, J. Fritzell, A.P. De Leon, J. Hallqvist SHEEP Study Group Neighborhood socioeconomic context, individual income and myocardial infarction Epidemiology 17 2006 14 23
45. R.D. Brook, B. Franklin, W. Cascio, Y.L. Hong, G. Howard, and M. Lipsett Air pollution and cardiovascular disease - a statement for healthcare professionals from the expert panel on population and prevention science of the American Heart Association Circulation 109 2004 2655 2671 (Pubitemid 38720571)
46. J.A. Spertus, P.G. Jones, F.A. Masoudi, J.S. Rumsfeld, and H.M. Krumholz Factors associated with racial differences in myocardial infarction outcomes Ann Intern Med 150 2009 314 324
47. A.J. Schulz, J.S. House, B.A. Israel, G. Mentz, J.T. Dvonch, and P.Y. Miranda Relational pathways between socioeconomic position and cardiovascular risk in a multiethnic urban sample: complexities and their implications for improving health in economically disadvantaged populations J Epidemiol Community Health 62 2008 638 646 (Pubitemid 351960227)
48. Y. Kiyota, S. Schneeweiss, R.J. Glynn, C.C. Cannuscio, J. Avorn, and D.H. Solomon Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records Am Heart J 148 2004 99 104 (Pubitemid 38900487)
49. A.V. Margulis, N.K. Choudhry, C.R. Dormuth, and S. Schneeweiss Variation in initiating secondary prevention after myocardial infarction by hospitals and physicians, 1997 through 2004 Pharmacoepidemiol Drug Saf 20 10 2011 1088 1097
50. J.D. Angrist Estimation of limited dependent variable models with dummy endogenous regressors: simple strategies for empirical practice J Business Econ Stat 19 2001 2 16 (Pubitemid 33586932)
51. J.D. Angrist, and J.-S. Pischke Mostly harmless econometrics: an empiricist's companion 2009 Princeton University Press Princeton, NJ
52. G. Chow Tests of equality between sets of coefficients in two linear models Econometrica 28 3 1960 591 605
53. J.A. Hausman Specification and estimation of simultaneous equation models Z. Griliches, M.D. Intriligator, Handbook of Econometrics Vol. 1 1983 North-Holland Publishing Company New York, NY 392 448
54. C.J.L. Murray, S.C. Kulkarni, C. Michaud, N. Tomijima, M.T. Bulzacchelli, and T.J. Iandiorio Eight Americas: investigating mortality disparities across races, counties, and race-counties in the United States (volume 3, page 4, 2005) PLoS Med 3 12 2006 1513 1524 (Pubitemid 44455262)
55. W.G. Cochran Some methods of strengthening the common chi-squared tests Biometrics 10 1954 417 451
56. P. Armitage Tests for linear trends in proportions and frequencies Biometrics 11 1955 375 386
57. J.J. Heckman Building bridges between structural and program approaches to evaluating policy J Econ Lit 68 2010 356 398
58. M. McClellan, and J.P. Newhouse Instrumental variables analysis applications in health services research - a special supplement to HSR - overview of supplement issue Health Serv Res 35 2000 1061 1069
59. C.N. Klabunde, A.L. Potosky, J.M. Legler, and J.L. Warren Development of a comorbidity index using physician claims data J Clin Epidemiol 53 2000 1258 1267 (Pubitemid 32007842)
60. D. Aujesky, D.S. Obrosky, R.A. Stone, T.E. Auble, A. Perrier, and J. Cornuz A prediction rule to identify low-risk patients with pulmonary embolism Arch Intern Med 166 2006 169 175 (Pubitemid 43144939)
61. L. Blais, C. Lemiere, D. Menzies, and D. Berbiche Validity of asthma diagnoses recorded in the Medical Services database of Quebec Pharmacoepidemiol Drug Saf 15 2006 245 252
62. D.W. Brown, J.B. Croft, W.H. Giles, R.F. Anda, and G.A. Mensah Epidemiology of pacemaker procedures among Medicare enrollees in 1990, 1995, and 2000 Am J Cardiol 95 2005 409 411 (Pubitemid 40164552)
63. Chronic Condition Warehouse, 27 Chronic condition algorithms, 2011. Available at www.ccwdata.org. Accessed February 1, 2012.
64. M.J. Cziraky, V.J. Wiley, J.M. McKenney, S.A. Kamat, M.D. Fisher, and J.R. Guyton Statin safety: an assessment using an administrative claims database Am J Cardiol 97 2006 61C 68C
65. A. Elixhauser, C. Steiner, D.R. Harris, and R.M. Coffey Comorbidity measures for use with administrative data Med Care 36 1998 8 27 (Pubitemid 128456396)
66. J. Fang, G.A. Mensah, M.H. Alderman, and J.B. Croft Trends in acute myocardial infarction complicated by cardiogenic shock, 1979-2003, United States Am Heart J 152 2006 1035 1041 (Pubitemid 44854794)
67. L.G. Glance, A.W. Dick, T.M. Osler, and D.B. Mukamel Accuracy of hospital report cards based on administrative data Health Serv Res 41 4 pt 1 2006 1413 1437 (Pubitemid 44114605)
68. M.R. Griffin, A. Yared, and W.A. Ray Nonsteroidal antiinflammatory drugs and acute renal failure in elderly persons Am J Epidemiol 151 2000 488 496 (Pubitemid 30471023)
69. A.F. Hernandez, A.M. Shea, C.A. Milano, J.G. Rogers, B.G. Hammill, and C.M. O'Connor Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries JAMA 300 2008 2398 2406
70. R. Liperoti, G. Gambassi, K.L. Lapane, C. Chiang, C. Pedone, and V. Mor Conventional and atypical antipsychotics and the risk of hospitalization for ventricular arrhythmias or cardiac arrest Arch Intern Med 165 2005 696 701 (Pubitemid 40393155)
71. F.L. Lucas, M.A. DeLorenzo, A.E. Siewers, and D.E. Wennberg Temporal trends in the utilization of diagnostic testing and treatments for cardiovascular disease in the United States, 1993-2001 Circulation 113 2006 374 379 (Pubitemid 43803198)
72. B.C. Lund, P.J. Perry, J.M. Brooks, and S. Arndt Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach Arch Gen Psychiatry 58 2001 1172 1176 (Pubitemid 33121510)
73. D.J. Malenka, A.V. Kaplen, F.L. Lucas, S.M. Sharp, and J.S. Skinner Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents JAMA 299 2008 2868 2876 (Pubitemid 351930886)
74. R.M. Carnahan Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative data: summary of findings and suggestions for future research Pharmacoepidemiol Drug Saf 21 Suppl 1 2012 90 99
75. K. Okrah, M. Vaughn-Sarrazin, and P. Cram Trends in echocardiography utilization in the Veterans Administration Healthcare System Am Heart J 159 2010 477 483
76. A.R. Reeves, R. Seshadri, and S.O. Trerotola Recent trends in central venous catheter placement: a comparison of interventional radiology with other specialties J Vasc Interv Radiol 12 2001 1211 1214 (Pubitemid 32983359)
77. J. Rello, D.A. Ollendorf, G. Oster, M. Ver-Llonch, L. Bellm, and R. Redman Epidemiology and outcomes of ventilator-associated pneumonia in a large US database Chest 122 2002 2115 2121 (Pubitemid 36051151)
78. P.S. Romano, M.E. Schembri, and J.A. Rainwater Can administrative data be used to ascertain clinically significant postoperative complications? Am J Med Qual 17 2002 145 154
79. P.A. Rochon, G.M. Anderson, J.V. Tu, J.P. Clark, J.H. Gurwitz, and J.P. Szalai Use of beta-blocker therapy in older patients after acute myocardial infarction in Ontario CMAJ 161 11 1999 1403 1408
80. M. Wilchesky, R.M. Tamblyn, and A. Huang Validation of diagnostic codes within medical services claims J Clin Epidemiol 57 2004 131 141 (Pubitemid 38668607)